Allergan, Inc.
U.S. Administrative Headquarters
Morris Corporate Center III, 400 Interpace Parkway
Parsippany
New Jersey
07054
United States
Tel: 1 (862) 261-7000
Website: http://www.allergan.com/
About Allergan, Inc.
Allergan plc (AGN), headquartered in Dublin, Ireland, is a unique, global pharmaceutical company and a leader in a new industry model – Growth Pharma. Allergan is focused on developing, manufacturing and commercializing innovative branded pharmaceuticals, high-quality generic and over-the-counter medicines and biologic products for patients around the world.
Allergan markets a portfolio of best-in-class products that provide valuable treatments for the central nervous system, eye care, medical aesthetics, gastroenterology, women's health, urology, cardiovascular and anti-infective therapeutic categories, and operates the world's third-largest global generics business, providing patients around the globe with increased access to affordable, high-quality medicines. Allergan is an industry leader in research and development, with one of the broadest development pipelines in the pharmaceutical industry.
We’re Looking for the World’s Best
At Allergan, we are committed to recruiting and retaining the industry’s best and brightest employees and are proud to offer opportunities for military veterans at all levels across our company. We offer business, scientific, technical, engineering, sales & marketing and a variety of other positions here in the U.S. and around the world.
At Allergan, you will find an entrepreneurial style work environment where employees and employee teams are encouraged to apply their unique talents to grow, contribute, innovate and excel. We welcome your ideas. We provide the support, resources and encouragement that enable you to take your career to new heights. We focus on challenging you, challenging ourselves and driving success.
Commit to your future and join us. Learn more about our exciting career opportunities at www.allergan.com/careers.
YEAR FOUNDED:
1948
LEADERSHIP:
Founder: Gavin S. Herbert
CEO: Brenton L. Saunders
CFO: Maria Teresa Hilado
CLINICAL TRIAL:
Please click here for clinical trial information.
PRODUCTS:
All Products
1188 articles about Allergan, Inc.
-
Allergan Inc. Files Answer In Federal Court Responding To Valeant Pharmaceuticals International And Pershing Square’s Counterclaims
9/2/2014
-
Allergan Inc. Announces OZURDEX® (Dexamethasone 700 Mcg Intravitreal Implant In Applicator) Now Approved In The European Union For The Treatment Of Diabetic Macular Edema
9/2/2014
-
Facing Shareholder Demands, Allergan Inc. Reluctantly Sets A Date For Special Meeting
8/27/2014
-
Allergan Inc. To Request California Federal Court Block Valeant Pharmaceuticals International And Pershing Square From Voting Shares Acquired In Violation Of Insider Trading Laws
8/27/2014
-
Pershing Square Submits Requisite Requests From Allergan Inc. Shareholders To Call Special Meeting
8/25/2014
-
Allergan Inc. Loses Battle To Make Shareholder Vote Moot On Valeant Pharmaceuticals International Bid
8/22/2014
-
Allergan Inc., Bristol-Myers Squibb Company On The Prowl For Space In Crowded Cambridge, Massachusetts
8/20/2014
-
Allergan Inc. CFO Steps Down In Midst Of Hostile Takeover Bid By Valeant Pharmaceuticals International
8/20/2014
-
Allergan Inc. Approaches Salix Pharmaceuticals, Ltd. To Fend Off Valeant Pharmaceuticals International's Hostile Bid
8/20/2014
-
Allergan Inc. Release: Nearly Half Of Women In New Survey Reveal That Their Current Treatments Are Not Adequately Addressing Overactive Bladder (OAB) Symptoms
8/19/2014
-
Valeant Pharmaceuticals International Extends Offer To Acquire Allergan Inc.
8/18/2014
-
Allergan Inc. Names Jim Hindman Chief Financial Officer
8/18/2014
-
SEC Investigating Valeant Pharmaceuticals International, Pershing Square's Hostile Takeover Bid For Allergan Inc.
8/15/2014
-
Allergan Inc. Grabs TARIS Biomedical's Lead Program In Deal Worth $587.5 Million
8/14/2014
-
Allergan Inc. Receives Second Request From Federal Trade Commission Regarding Valeant Pharmaceuticals International’s Unsolicited Acquisition Proposal
8/11/2014
-
Allergan Inc. Layoffs: Employees Tell Their Side Of The Story
8/8/2014
-
Institutional Shareholder Services (ISS) Recommends Allergan Inc. Shareholders Call A Special Meeting Of Shareholders
8/7/2014
-
Advisor ISS Backs Ackman's Call For Allergan Inc. Meeting, Event Could Support The Removal Of Directors, Sale To Valeant Pharmaceuticals International
8/7/2014
-
Valeant Pharmaceuticals International And Pershing Square Respond To Frivolous Allergan Inc. Lawsuit
8/4/2014
-
Allergan Inc. R&D Innovations Recognized With Three Nominations For The 2014 U.S. Prix Galien Awards
8/4/2014